Navigation Links
Toxic effects common with AIDS treatments

High levels of toxic effects associated with antiretroviral treatment for HIV have been recorded and quantified by a group of Swiss researchers in a study published this week in The Lancet. If efficacy levels of drug combinations are similar, treatment choice will depend on the toxic effects of the drugs. Therefore, the data may be useful as a reference for future analyses of adverse effects of different treatment regimens. //

Dr Jacques Fellay from the University Hospital of Lausanne, and colleagues from the Swiss HIV Cohort Study, identified 1,160 HIV-positive patients receiving antiretroviral treatment for their condition. The researchers found that 47 per cent of patients taking part in the study exhibited clinical and 27 per cent exhibited laboratory evidence of drug-related adverse effects. Analysis of symptoms revealed that 9 per cent of those with clinical adverse symptoms and 30 per cent of those with laboratory adverse symptoms were serious or severe.

Fatigue and headache were reported by 37 and 22 per cent of the patient population, respectively. The researchers identified specific associations between different compounds, including lipodystrophy and high creatine phosphokinase concentrations with stavudine, thrombocytopaenia with saquinavir, mood disorders with lamivudine and hyperlactataemia with didanosine and stavudine. However, the reported effects of a particular drug are associated with levels of its actual use, and this is likely to be reflected in the data collected, the researchers warn.


'"/>




Page: 1

Related medicine news :

1. Toxic chemicals found in domestic products poisoning newborn babies
2. Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis
3. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
4. Passive smoking declared as Toxic in California
5. Bacteria Can Convert Flame Retardant Into Toxic Form
6. "Miracle" Cancer Drug Gleevec Can be Toxic to the Heart
7. Agricultural Workers Taken ill after Inhaling Toxic Fumes in Orissa
8. Toxic and Addictive Foods Responsible For Obesity
9. Herceptin Use May Enhance Cardiac Toxicity, Study
10. Scientists Develop Non-Toxic, Food Safe Paint
11. Toxic Strand Of RNA Causes Myotonic Muscular dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
Breaking Medicine Technology: